Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
T-Vec
Biotech
Oncorus raises $80M for 2-front oncolytic virus R&D push
The series B round equips Oncorus to move its lead asset into the clinic and nominate an intravenously administered viral candidate early next year.
Nick Paul Taylor
Aug 21, 2019 7:00am
A 3-pronged attack on melanoma
Dec 12, 2018 2:00pm
Oncolytics player Replimune bags $55M to hit clinical POC
Sep 8, 2017 9:50am
Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC
Oct 25, 2016 2:47pm